244 related articles for article (PubMed ID: 25830650)
21. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.
Yang SJ; Nast CC; Mishra NN; Yeaman MR; Fey PD; Bayer AS
Antimicrob Agents Chemother; 2010 Aug; 54(8):3079-85. PubMed ID: 20498310
[TBL] [Abstract][Full Text] [Related]
22. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
[TBL] [Abstract][Full Text] [Related]
23. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
[TBL] [Abstract][Full Text] [Related]
24. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
[TBL] [Abstract][Full Text] [Related]
25. Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
Yin Y; Chen H; Li S; Gao H; Sun S; Li H; Wang R; Jin L; Liu Y; Wang H
Int J Antimicrob Agents; 2019 Dec; 54(6):673-680. PubMed ID: 31479743
[TBL] [Abstract][Full Text] [Related]
26. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.
Friedman L; Alder JD; Silverman JA
Antimicrob Agents Chemother; 2006 Jun; 50(6):2137-45. PubMed ID: 16723576
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of mprF and dltABCD expression among daptomycin-non-susceptible MRSA clinical isolates.
Bayer AS; Mishra NN; Cheung AL; Rubio A; Yang SJ
J Antimicrob Chemother; 2016 Aug; 71(8):2100-4. PubMed ID: 27121398
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons.
Mishra NN; Bayer AS; Weidenmaier C; Grau T; Wanner S; Stefani S; Cafiso V; Bertuccio T; Yeaman MR; Nast CC; Yang SJ
PLoS One; 2014; 9(9):e107426. PubMed ID: 25226591
[TBL] [Abstract][Full Text] [Related]
29. Investigating a possible link between antiseptic treatment and the increased occurrence of daptomycin-resistant Staphylococcus aureus.
Wendel AF; Otchwemah R; Layer-Nicolaou F; Mattner F; Tellez-Castillo CJ; Skov R; Oberländer H; Werner G; Strommenger B
Clin Microbiol Infect; 2023 Oct; 29(10):1334.e1-1334.e6. PubMed ID: 37321393
[TBL] [Abstract][Full Text] [Related]
30. VraH Is the Third Component of the Staphylococcus aureus VraDEH System Involved in Gallidermin and Daptomycin Resistance and Pathogenicity.
Popella P; Krauss S; Ebner P; Nega M; Deibert J; Götz F
Antimicrob Agents Chemother; 2016 Apr; 60(4):2391-401. PubMed ID: 26856834
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial mechanism of daptomycin antibiotic against Staphylococcus aureus based on a quantitative bacterial proteome analysis.
Ma W; Zhang D; Li G; Liu J; He G; Zhang P; Yang L; Zhu H; Xu N; Liang S
J Proteomics; 2017 Jan; 150():242-251. PubMed ID: 27693894
[TBL] [Abstract][Full Text] [Related]
32. Sensitizing
Slavetinsky CJ; Hauser JN; Gekeler C; Slavetinsky J; Geyer A; Kraus A; Heilingbrunner D; Wagner S; Tesar M; Krismer B; Kuhn S; Ernst CM; Peschel A
Elife; 2022 Jan; 11():. PubMed ID: 35044295
[TBL] [Abstract][Full Text] [Related]
33. Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model.
Steed ME; Vidaillac C; Rose WE; Winterfield P; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 2011 Oct; 55(10):4748-54. PubMed ID: 21788457
[TBL] [Abstract][Full Text] [Related]
34. Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.
Jiang JH; Dexter C; Cameron DR; Monk IR; Baines SL; Abbott IJ; Spelman DW; Kostoulias X; Nethercott C; Howden BP; Peleg AY
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617095
[TBL] [Abstract][Full Text] [Related]
35. Daptomycin Tolerance in the Staphylococcus aureus pitA6 Mutant Is Due to Upregulation of the dlt Operon.
Mechler L; Bonetti EJ; Reichert S; Flötenmeyer M; Schrenzel J; Bertram R; François P; Götz F
Antimicrob Agents Chemother; 2016 May; 60(5):2684-91. PubMed ID: 26883712
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
Julian K; Kosowska-Shick K; Whitener C; Roos M; Labischinski H; Rubio A; Parent L; Ednie L; Koeth L; Bogdanovich T; Appelbaum PC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3445-8. PubMed ID: 17620372
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
Anastasiou DM; Morgan M; Ruane PJ; Steenbergen JN; Katz BD; Alder JD; Thorne GM
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):339-42. PubMed ID: 18304772
[TBL] [Abstract][Full Text] [Related]
38. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH; Firsov AA
Int J Antimicrob Agents; 2007 Feb; 29(2):165-9. PubMed ID: 17207607
[TBL] [Abstract][Full Text] [Related]
39. Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems.
Müller A; Grein F; Otto A; Gries K; Orlov D; Zarubaev V; Girard M; Sher X; Shamova O; Roemer T; François P; Becher D; Schneider T; Sahl HG
Int J Med Microbiol; 2018 Apr; 308(3):335-348. PubMed ID: 29429584
[TBL] [Abstract][Full Text] [Related]
40. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
Howden BP; McEvoy CR; Allen DL; Chua K; Gao W; Harrison PF; Bell J; Coombs G; Bennett-Wood V; Porter JL; Robins-Browne R; Davies JK; Seemann T; Stinear TP
PLoS Pathog; 2011 Nov; 7(11):e1002359. PubMed ID: 22102812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
